Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1032568-63-0
Purity
95%
Copanlisib is a medication used to treat relapsed follicular lymphoma. It is a selective pan-Class I phosphoinositide 3-kinase (PI3K/Phosphatidylinositol-4,5-bisphosphate 3-kinase/phosphatidylinositide 3-kinase) inhibitor. The active ingredient in Aliqopa intravenous therapy is copanlisib dihydrochloride.
Properties
Name
Copanlisib
Smiles
COC=1C(OCCCN2CCOCC2)=CC=C3C4=NCCN4C(=NC13)NC(=O)C=5C=NC(N)=NC5
Targets
Please log in to see this information
Aliqopa | BAY 80-6946 | copanlisib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$37
2 mg
$39
5 mg
$41
10 mg
$43
15 mg
$45
20 mg
$48
25 mg
$53
30 mg
$56
35 mg
$59
40 mg
$61
45 mg
$64
50 mg
$66
75 mg
$69
100 mg
$POA
Quantity
1
Total amount
$ 41
Aliqopa | BAY 80-6946 | copanlisib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:1402152-13-9
0
CAS:1032568-63-0
0